ITGAM and neoplasm: Our data show that SLR14 is mainly taken up by CD11b+ myeloid cells, which could include Ly6G+ tumor-associated neutrophils, tumor-associated macrophages, and tumor-associated DCs (including Ly6C+ inflammatory DC subset).